Buy LVAD Now, Pay Later: WorldHeart Floats Financing Model In U.S. Market
This article was originally published in The Gray Sheet
Executive Summary
WorldHeart will rely on a financing deal with Export Development Canada (EDC) to boost international sales of the Novacor left-ventricular assist device
You may also be interested in...
New WorldHeart CEO Cuts Costs, Redirects Firm To California Roots
WorldHeart plans to eliminate its Ottawa operations by March 31 as part of the firm's shift from a new technology start-up to a commercially successful device manufacturer
New WorldHeart CEO Cuts Costs, Redirects Firm To California Roots
WorldHeart plans to eliminate its Ottawa operations by March 31 as part of the firm's shift from a new technology start-up to a commercially successful device manufacturer
European LVAD registry
Two-to-three year left-ventricular assist device registry will track patients in an effort to convince European governments of the quality of life benefits and spur reimbursement. Sparked by collaboration between Eucomed and LVAD manufacturers, the registry will focus both on bridge-to-transplant and destination therapy patients. In the U.S., a Medicare coverage decision for LVADs currently is slated for September, following several delays by CMS (1"The Gray Sheet" Aug. 18, 2003, p. 11)...